Live from the NIH registry
Studies recruiting near Leesburg right now
Top 25 of 156 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
K2 MEDICAL Research THE VILLAGES — Lady Lake, Florida (10.5 mi)
· Sponsor: Bristol-Myers Squibb
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Clermont Oncology Center — Clermont, Florida (16.8 mi)
· Sponsor: Eli Lilly and Company
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Florida Retina Institute Wildwood — Wildwood, Florida (11.1 mi)
· Sponsor: Boehringer Ingelheim
AngelMed Guardian® System PMA Post Approval Study
Acute Coronary Syndrome
N/A
Observational 500 participants sought
Clermont Ambulatory Surgical Center — Clermont, Florida (16.8 mi)
· Sponsor: Angel Medical Systems
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Health Central — Ocoee, Florida (25.4 mi)
· Sponsor: NRG Oncology
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Diabetes Mellitus, Type 2
Phase 2
Interventional 270 participants sought
West Orange Endocrinology — Ocoee, Florida (25.4 mi)
· Sponsor: Novo Nordisk A/S
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
Phase 1, Phase 2
Interventional 340 participants sought
Clermont Oncology Center — Clermont, Florida (16.8 mi)
· Sponsor: Inhibrx Biosciences, Inc
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Clermont Oncology Center ( Site 0046) — Clermont, Florida (16.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Alzheimer's Disease
Phase 2
Interventional 407 participants sought
Charter Research The Villages — The Villages, Florida (12.2 mi)
· Sponsor: Novartis Pharmaceuticals
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Clermont, Florida (16.8 mi)
· Sponsor: GlaxoSmithKline
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Overweight, Obesity
Phase 2
Interventional 400 participants sought
Charter Research - Lady Lake — The Villages, Florida (12.2 mi)
· Sponsor: Eli Lilly and Company
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Health Central — Ocoee, Florida (25.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of LY3439539 in Participants With Alzheimer's Disease
Alzheimer Disease
Phase 1
Interventional 30 participants sought
K2 Medical Research - The Villages — Lady Lake, Florida (10.5 mi)
· Sponsor: Eli Lilly and Company
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
Dementia, Alzheimer's Type, Alzheimer's Disease
Phase 2
Interventional 160 participants sought
Charter Research - Lady Lake- Site Number : 8400004 — The Villages, Florida (12.2 mi)
· Sponsor: Sanofi
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Malignant Neoplasm
Phase 2
Interventional 140 participants sought
Clermont Oncology Center ( Site 0041) — Clermont, Florida (16.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis (MASH)
Phase 1, Phase 2
Interventional 56 participants sought
Kriya Clinical Trial Site — Lady Lake, Florida (10.5 mi)
· Sponsor: Kriya Therapeutics, Inc.
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
Alzheimer Disease, Amyloid
Phase 1
Interventional 179 participants sought
K2 Medical Research - The Villages — Lady Lake, Florida (10.5 mi)
· Sponsor: Eli Lilly and Company
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Lady Lake, Florida (10.5 mi)
· Sponsor: Hoffmann-La Roche
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Nature Coast Clinical Research — Inverness, Florida (26.7 mi)
· Sponsor: Janssen Research & Development, LLC
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
K2 MEDICAL Research THE VILLAGES — Lady Lake, Florida (10.5 mi)
· Sponsor: Eli Lilly and Company
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Diabetic Peripheral Neuropathic Pain
Phase 2
Interventional 150 participants sought
K2 MEDICAL Research THE VILLAGES — Lady Lake, Florida (10.5 mi)
· Sponsor: Eli Lilly and Company
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Type 2 Diabetes Mellitus, Type 2 Diabetes With Chronic Kidney Disease
Phase 3
Interventional 900 participants sought
Research Site — Leesburg, Florida (3.2 mi)
· Sponsor: AstraZeneca
Patient Retrospective Outcomes (PRO)
Chronic Pain
N/A
Observational 15,000 participants sought
Orlando Health Neuroscience Institute — Clermont, Florida (16.8 mi)
· Sponsor: Boston Scientific Corporation
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
Breast Cancer
N/A
Interventional 2,032 participants sought
Lake Medical Imaging — The Villages, Florida (12.2 mi)
· Sponsor: American College of Radiology
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
K2 MEDICAL Research THE VILLAGES — Lady Lake, Florida (10.5 mi)
· Sponsor: Eli Lilly and Company